125 related articles for article (PubMed ID: 21371786)
1. Neuronal histamine production remains unaltered in Parkinson's disease despite the accumulation of Lewy bodies and Lewy neurites in the tuberomamillary nucleus.
Shan L; Liu CQ; Balesar R; Hofman MA; Bao AM; Swaab DF
Neurobiol Aging; 2012 Jul; 33(7):1343-4. PubMed ID: 21371786
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
3. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
Hill WD; Arai M; Cohen JA; Trojanowski JQ
J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
[TBL] [Abstract][Full Text] [Related]
4. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
[TBL] [Abstract][Full Text] [Related]
5. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
[TBL] [Abstract][Full Text] [Related]
6. [The mechanism of Lewy body formation in Parkinson's disease].
Wakabayashi K; Takahashi H
Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441
[TBL] [Abstract][Full Text] [Related]
7. A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease.
Pouclet H; Lebouvier T; Coron E; Des Varannes SB; Neunlist M; Derkinderen P
Neurogastroenterol Motil; 2012 Apr; 24(4):e202-5. PubMed ID: 22292943
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease.
Lu L; Neff F; Alvarez-Fischer D; Henze C; Xie Y; Oertel WH; Schlegel J; Hartmann A
Exp Neurol; 2005 Sep; 195(1):27-39. PubMed ID: 15944136
[TBL] [Abstract][Full Text] [Related]
9. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
10. Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: four cases.
Del Tredici K; Duda JE
J Neurol Sci; 2011 Nov; 310(1-2):100-6. PubMed ID: 21689832
[TBL] [Abstract][Full Text] [Related]
11. Three-layered structure shared between Lewy bodies and lewy neurites-three-dimensional reconstruction of triple-labeled sections.
Kanazawa T; Uchihara T; Takahashi A; Nakamura A; Orimo S; Mizusawa H
Brain Pathol; 2008 Jul; 18(3):415-22. PubMed ID: 18394008
[TBL] [Abstract][Full Text] [Related]
12. Lewy bodies in Betz cells of the motor cortex in a patient with Parkinson's disease.
Wakabayashi K; Mori F; Oyama Y; Kurihara A; Kamada M; Yoshimoto M; Takahashi H
Acta Neuropathol; 2003 Feb; 105(2):189-92. PubMed ID: 12536231
[TBL] [Abstract][Full Text] [Related]
13. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.
Yamamoto S; Fukae J; Mori H; Mizuno Y; Hattori N
Neurosci Lett; 2006 Apr; 396(3):187-91. PubMed ID: 16386370
[TBL] [Abstract][Full Text] [Related]
14. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
[TBL] [Abstract][Full Text] [Related]
15. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?
Halliday G; McCann H; Shepherd C
Expert Rev Neurother; 2012 Jun; 12(6):673-86. PubMed ID: 22650170
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the histaminergic system in the substantia nigra and striatum of Parkinson's patients: a postmortem study.
Shan L; Bossers K; Luchetti S; Balesar R; Lethbridge N; Chazot PL; Bao AM; Swaab DF
Neurobiol Aging; 2012 Jul; 33(7):1488.e1-13. PubMed ID: 22118942
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
19. Controversy: is Parkinson's disease a single disease entity? Yes.
Takahashi H; Wakabayashi K
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
[TBL] [Abstract][Full Text] [Related]
20. TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease.
Shashidharan P; Good PF; Hsu A; Perl DP; Brin MF; Olanow CW
Brain Res; 2000 Sep; 877(2):379-81. PubMed ID: 10986355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
